Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics in Mild Alzheimer's Disease
NCT06181513Phase 1Recruiting
- Sponsor
- University of Nicosia
- Start
- Dec 2022
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Alzheimer's disease (AD) (2 arms), sponsored by University of Nicosia. Primary endpoint: Level of inflammatory markers at 16 weeks. Started Dec 2022; status: recruiting.
02
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT06181513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06181513.